Assessment of changes in nicotine dependence, motivation, and symptoms of anxiety and depression among smokers in the initial process of smoking reduction or cessation: a short-term follow-up study
Avaliação de mudanças na dependência da nicotina, motivação e sintomas de ansiedade e depressão em fumantes no processo inicial de redução ou cessação do tabagismo: estudo de seguimento de curto prazo
Luciana Rizzieri Figueiró; Cassandra Borges Bortolon; Mariana Canellas Benchaya; Nadia Krubskaya Bisch; Maristela Ferigolo; Helena Maria Tannhauser Barros; Denise Conceição Mesquita Dantas
Abstract
Keywords
Resumo
Palavras-chave
References
WHO Report on the Global Tobacco Epidemic, 2008 - The MPOWER package. 2008.
Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29-38.
Carlini EA, Galduróz JC, Noto AR. II Levantamento domiciliar sobre o uso de drogas psicotrópicas no Brasil: estudo envolvendo as 108 maiores cidades do país - 2005. 2007.
Azevedo RC, Fernandes RF. Factors relating to failure to quit smoking: a prospective cohort study. Sao Paulo Med J. 2011;129:380-6.
Lopes FL, Nascimento I, Zin WA, Valença AM, Mezzasalma MA, Figueira I. Smoking and psychiatric disorders: a comorbidity survey. Braz J Med Biol Res. 2002;35:961-7.
Benowitz NL. Smoking less as a treatment goal for those who cannot stop smoking. Am J Med. 2004;116:203-5.
Peters EN, Hughes JR. The day-to-day process of stopping or reducing smoking: a prospective study of self-changers. Nicotine Tob Res. 2009;11:1083-92.
Stead LF, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database Syst Rev. 2007:CD005231.
Hughes JR, Carpenter MJ. Does smoking reduction increase future cessation and decrease disease risk: A qualitative review. Nicotine Tob Res. 2006;8:739-49.
Ferguson SG, Gitchell JG, Shiffman S, Sembower MA. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Clin Ther. 2009;31:1957-65.
Powell J, Dawkins L, West R, Powell J, Pickering A. Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology (Berl). 2010;212(4):537-49.
Weinberger AH, McKee SA, George TP. Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation. Nicotine Tob Res. 2010;12:937-43.
Tomson T, Toftgard M, Gilljam H, Helgason AR. Symptoms in smokers trying to quit. Tob Induc Dis. 2006;3:44-58.
Herd N, Borland R, Hyland A. Predictors of smoking relapse by duration of abstinence: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction. 2009;104:2088-99.
Aguiar M, Todo-Bom F, Felizardo M, Macedo R, Caeiro F, Sotto-Mayor R. Four years' follow up at a smoking cessation clinic. Rev Port Pneumol. 2009;15:179-97.
McClave AK, Dube SR, Strine TW, Kroenke K, Caraballo RS, Mokdad AH. Associations between smoking cessation and anxiety and depression among U.S. adults. Addict Behav. 2009;34:491-7.
Mykletun A, Overland S, Aaro LE, Liabo HM, Stewart R. Smoking in relation to anxiety and depression: evidence from a large population survey: the HUNT study. Eur Psychiatry. 2008;23:77-84.
Freshstart. 1996.
Brasil . Ajudando seu paciente a deixar de fumar. 1997.
Carmo JT, Pueyo AA. A adaptação do português do Fagerström Test for Nicotine Dependence (FTND) para avaliar a dependência e tolerância à nicotina em fumantes brasileiros. Rev Bras Med. 2002;58:73-80.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86:1119-27.
Figlie NB. Metodologia de pesquisa em dependência química. XIV Congresso Brasileira de Alcoolismo, Tabagismo e Outras Dependências;. 2001.
McConnaughy EA, Prochaska JO, Velicer WF. Stages of change in psychotherapy: measurement and sample profiles. Psychother Theory Res Pract. 1983;20:368-75.
Biener L, Abrams DB. The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol. 1991;10:360-5.
Terra MB, da Silveira DX, Moreira TC, Ferigolo M, Mazoni C, Arena FX. Convergent validation study of the Contemplation Ladder for application via telephone in tobacco users. J Bras Psiquiatr. 2009;58:143-9.
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893-7.
Cunha JA. Manual da versão em português das escalas Beck. 2001.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-71.
Peach H, Ellard GA, Jenner PJ, Morris RW. A simple, inexpensive urine test of smoking. Thorax. 1985;40:351-7.
Okayama A, Sato T. Assessment of smoking status among workers using an improved colorimetric method. Ind Health. 2004;42:348-51.
Smith RF, Mather HM, Ellard GA. Assessment of simple colorimetric procedures to determine smoking status of diabetic subjects. Clin Chem. 1998;44:275-80.
Taylor P. Agents acting at the neuromuscular junction and autonomic ganglia. Goodman and Gilman's the pharmacological basis of therapeutics. 2006.
Cope G, Nayyar P, Holder R, Gibbons J, Bunce R. A simple near-patient test for nicotine and its metabolites in urine to assess smoking habit. Clin Chim Acta. 1996;256:135-49.
Asfar T, Weg MV, Maziak W, Hammal F, Eissenberg T, Ward KD. Outcomes and adherence in Syria's first smoking cessation trial. Am J Health Behav. 2008;32:146-56.
Chatkin JM. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?. Addiction. 2004;99:778-84.
Hagimoto A, Nakamura M, Morita T, Masui S, Oshima A. Smoking cessation patterns and predictors of quitting smoking among the Japanese general population: a 1-year follow-up study. Addiction. 2010;105:164-73.
Hukkanen J, Jacob P, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005;57:79-115.
Balhara YP, Jain R, Sundar AS, Sagar R. Use of cotinine urinalysis to verify self-reported tobacco use among male psychiatric out-patients. Lung India. 2012;29:217-20.
Connor Gorber S, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009;11:12-24.
Noonan D, Jiang Y, Duffy SA. Utility of biochemical verification of tobacco cessation in the Department of Veterans Affairs. Addict Behav. 2013;38:1792-5.
Pérez-Stable EJ, Marín G, Marín BV, Benowitz NL. Misclassification of smoking status by self-reported cigarette consumption. Am Rev Respir Dis. 1992;145:53-7.
Helgason AR, Tomson T, Lund KE, Galanti R, Ahnve S, Gilljam H. Factors related to abstinence in a telephone helpline for smoking cessation. Eur J Public Health. 2004;14:306-10.
Peters EN, Hughes JR, Callas PW, Solomon LJ. Goals indicate motivation to quit smoking. Addiction. 2007;102:1158-63.
Boardman T, Catley D, Mayo MS, Ahluwalia JS. Self-efficacy and motivation to quit during participation in a smoking cessation program. Int J Behav Med. 2005;12:266-72.
Nerín I, Beamonte A, Gargallo P, Jiménez-Muro A, Marqueta A. Ganancia ponderal al dejar de fumar y su relación con la ansiedad. Arch Bronconeumol. 2007;43:9-15.
Figueiró LR. Características de fumantes associadas à adesão ao tratamento e à mudança de comportamento. .
Zvolensky MJ, Stewart SH, Vujanovic AA, Gavric D, Steeves D. Anxiety sensitivity and anxiety and depressive symptoms in the prediction of early smoking lapse and relapse during smoking cessation treatment. Nicotine Tob Res. 2009;11:323-31.
Curtin L, Brown RA, Sales SD. Determinants of attrition from cessation treatment in smokers with a history of major depressive disorder. Psychol Addict Behav. 2000;14:134-42.
Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001;357:1929-32.
Picciotto MR. Common aspects of the action of nicotine and other drugs of abuse. Drug Alcohol Depend. 1998;51:165-72.
Park ER, Chang Y, Quinn V, Regan S, Cohen L, Viguera A. The association of depressive, anxiety, and stress symptoms and postpartum relapse to smoking: a longitudinal study. Nicotine Tob Res. 2009;11:707-14.
Camarelles F, Asensio A, Jiménez-Ruiz C, Becerril B, Rodero D, Vidaller O. Efectividad de la intervención grupal para la deshabituación tabáquica: Ensayo clínico aleatorizado. Med Clin (Barc). 2002;119:53-7.
Terra MB, Barros HM, Stein AT, Figueira I, Palermo LH, Athayde LD. Do alcoholics anonymous groups really work: Factors of adherence in a Brazilian sample of hospitalized alcohol dependents. Am J Addict. 2008;17:48-53.